Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)

CUSIP: G8807B106

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 7 signals
Share change
-1,998,549
Put/Call ratio
466%
SEC-reported price per share
$17.00
Number of holders
179
Value change
-$32,281,733
Number of buys
98
Open additional details 1 more signal available
Number of sells
80
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
52,046,621

Security key

G8807B106

Report period

Q2 2026

Institutions

179

Top holders

10

Ownership snapshot

Top reported holders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
179
Shares
48,094,274
Rows available
179
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
172
Q2 2026 holders
179
Holder diff
7
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .